Evidence map›Paper›PMID 26097613›Full record

ArticleInternational journal of clinical and experimental pathology2015

P120 catenin attenuates lipopolysaccharide-induced blood-brain barrier dysfunction and inflammatory responses in human brain microvascular endothelial cells.

Na Liu, Ai-Li Li, Xiao-Ping Zhou, Qiang Chen, Wei Cao

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Functions of p120-catenin in physiology and diseases.Frontiers in molecular biosciences · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Na LiuDepartment of Neurology, The Affiliated People's Hospital of Jiangsu University Zhenjiang 212000, Jiangsu, People's Republic of China.
Ai-Li LiDepartment of Neurology, The Second Hospital of Jilin University Changchun 130000, Jilin, People's Republic of China.
Xiao-Ping ZhouDepartment of Neurology, The Affiliated People's Hospital of Jiangsu University Zhenjiang 212000, Jiangsu, People's Republic of China.
Qiang ChenDepartment of Neurology, The Affiliated People's Hospital of Jiangsu University Zhenjiang 212000, Jiangsu, People's Republic of China.
Wei CaoDepartment of Neurology, The Affiliated People's Hospital of Jiangsu University Zhenjiang 212000, Jiangsu, People's Republic of China.
Jiangsu University · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidences suggest that p120 catenin (p120ctn) exerts important functions in the regulation of pro-inflammatory molecules. However, the relationship among p120ctn, inflammatory responses and blood-brain barrier (BBB) dysfunction as they are the initiator of sepsis is not unknown. In this study, we found that p120ctn expression was correlated with an increase in the permeability of BBB and a decrease in the expression of tight-junction proteins in human brain microvascular endothelial cells (HBMECs) after LPS challenge. Transfection with p120ctn small interfering RNA (siRNA) induced disruption of BBB integrity, monocyte migration across BBB and inflammatory responses at basal level and after LPS treatment. Conversely, over-expression of p120ctn with adenovirus significantly ameliorated BBB disruption and inflammatory responses in LPS-treated cells. Mechanistically, up-regulation of p120ctn inhibited LPS-induced NF-κB activation by suppressing IKKβ and IκBα phosphorylation, IκBα degradation. Therefore, we conclude that p120ctn improves the BBB dysfunction and inflammatory responses through the inhibition of NF-κB activation, suggesting that forced p120ctn expression may provide a novel therapeutic strategy to attenuate LPS-induced BBB compromise and sepsis.

Indexed as

Blood-Brain BarrierCapillary PermeabilityCateninsCell LineDelta CateninHumansI-kappa B KinaseI-kappa B ProteinsInflammationLipopolysaccharidesMicrovesselsNF-kappa BNF-KappaB Inhibitor alphaPhosphorylationProteolysisRNA InterferenceCateninsCTNND1 protein, humanDelta CateninI-kappa B KinaseI-kappa B ProteinsIKBKB protein, humanLipopolysaccharidesNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanTight Junction ProteinsBBBHBMECsinflammatory responseLPSp120ctn

Identifiers

PMID26097613
PMCPMC4467000
OpenAlexW2396154671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.